From: Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand
(a) P. falciparum | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Patient group | Mefloquine (250 mg tablet) | Primaquine (mg) | ||||||||
< 1 year | 1/2 | - | ||||||||
1–3 years | 3/4 | 5 | ||||||||
4–8 years | 1 1/2 | 10 | ||||||||
9–14 years | 2 | 15 | ||||||||
15+ years | 3 | 30 | ||||||||
(b) P. vivax | ||||||||||
Patient group | Day 1 | Day 2 | Day 3 | Day 4 | ||||||
C* | C* | C* | P+ | C* | P+ | C* | P+ | C* | P+ | |
< 6 m | 1/2 | - | - | - | 1/2 | - | - | - | - | - |
6–11 m | 1 | - | - | - | 1/2 | 1 | 1/2 | - | - | - |
1–3 y | 1 | 1 | - | 2.5 | 1 | 2.5 | 1 | 2.5 | 1 | 2.5 |
4–8 y | 1 | 1 | 1 | 5 | 1 | 5 | 1 | 5 | 1 | 5 |
9–14 y | 2 | 2 | - | 10 | 1 | 10 | 1 | 10 | 1 | 10 |
15+y | 2 | 2 | 2 | 15 | 2 | 15 | 2 | 15 | 2 | 15 |